# Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)

> **NCT00166595** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 100 (—)

## Conditions studied

- Child Development Disorders, Pervasive

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00166595
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 100 (—)
- **Last updated:** 2014-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00166595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00166595, "Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00166595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*